Principles of Pharmacology The Pathophysiologic Basis of Drug
Principles of Pharmacology The Pathophysiologic Basis of Drug Therapy Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Chapter 22 Pharmacology of Hemostasis and Thrombosis Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Sequence of Events in Hemostasis • Figure 22 -1 Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Platelet Adhesion and Aggregation • Figure 22 -2 Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Platelet Activation • Figure 22 -3 Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Platelet Activation by Thromboxane A 2 • Figure 22 -4 Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Platelet Activation by ADP and Thrombin • Figure 22 -5 Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Coagulation Cascade • Figure 22 -6 Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Coagulation Factor Activation on Phospholipid Surfaces • Figure 22 -7 Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Central Role of Thrombin in the Coagulation Cascade • Figure 22 -8 Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Antithrombin III Action • Figure 22 -9 Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
The Fibrinolytic System • Figure 22 -10 Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Virchow’s Triad • Figure 22 -11 Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Overview of Prostaglandin Synthesis • Figure 22 -12 Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Mechanism of Action of Antiplatelet Agents • Figure 22 -13 Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Mechanism of Action of Warfarin • Figure 22 -14 Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Differential Effects of Unfractionated Heparin, Low-Molecular. Weight Heparins, Selective Factor Xa Inhibitors, and Direct Thrombin Inhibitors on Coagulation Factor Inactivation • Figure 22 -15 Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
- Slides: 17